Achieving universal access to rapid tuberculosis diagnostics by Tereza Kasaeva, Matteo Zignol, Nazir Ismail, Carl-Michael Nathanson

Get full text

Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from B... by Grania Brigden, Nguyen Viet Nhung, Alena Skrahina, Norbert Ndjeka, Dennis Falzon, Matteo Zignol

Get full text

Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. by Ted Cohen, Caroline Colijn, Bryson Finklea, Abigail Wright, Matteo Zignol, Alexander Pym, Megan Murray

Get full text

Advances in clinical trial design: Weaving tomorrow's TB treatments. by Christian Lienhardt, Andrew Nunn, Richard Chaisson, Andrew A Vernon, Matteo Zignol, Payam Nahid, Eric Delaporte, Tereza Kasaeva

Get full text

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis. by Aastha Gupta, Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Saurabh Rane, Fuad Mirzayev, Matteo Zignol

Get full text

WHO target product profile for TB detection at peripheral settings: 2024 update by Mikashmi Kohli, Alexei Korobitsyn, Nazir Ismail, Matteo Zignol, Tereza Kasaeva, Puneet Dewan, Morten Ruhwald, the Scientific TPP Development group

Get full text

Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya. by Julia Jezmir, Ted Cohen, Matteo Zignol, Edwin Nyakan, Bethany L Hedt-Gauthier, Adrian Gardner, Lydia Kamle, Wilfred Injera, E Jane Carter

Get full text

The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey. by Paul Aia, Margaret Kal, Evelyn Lavu, Lucy N John, Karen Johnson, Chris Coulter, Julia Ershova, Olga Tosas, Matteo Zignol, Shalala Ahmadova, Tauhid Islam

Get full text

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. by Allison Portnoy, Jean-Louis Arcand, Rebecca A Clark, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G White, Nicolas A Menzies

Get full text

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres. by Emily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, Matteo Chiacchiaretta, Timothy M Walker, Martina Casenghi, Camilla Rodrigues, Timothy C Rodwell, Philip Supply, Emmanuel André, Mikashmi Kohli, Morten Ruhwald, Daniela Maria Cirillo, Nazir Ismail, Matteo Zignol

Get full text

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data. by Anna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, Dennis Falzon, Philippe Glaziou, Daniela Maria Cirillo, Claudio U Köser, Lice Y Gonzalez-Angulo, Olga Tosas-Auget, Nazir Ismail, Sabira Tahseen, Maria Cecilia G Ama, Alena Skrahina, Natavan Alikhanova, S M Mostofa Kamal, Katherine Floyd

Get full text

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. by Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies

Get full text